29/06
9:00 - 9:15
Auditorium

Introduction

Session

Moderator: Eric SOUIED (FRANCE)

Introduction

Mayer SROUR (FRANCE), Sarah TICK (FRANCE)

29/06
9:15 - 10:30
Auditorium

GEOGRAPHIC ATROPHY

Session

Moderators: Caroline BAUMAL (UNITED STATES), Giuseppe QUERQUES (ITALY), Philip ROSENFELD (UNITED STATES)

09:16 - 09:24
Baseline Characteristics Associated with Progression of Geographic Atrophy 

Caroline BAUMAL (UNITED STATES)

09:24 - 09:32
Photobiomodulation for Geographic Atrophy: What’s Going On?

Neil BRESSLER (UNITED STATES)

09:32 - 09:40
Understanding Cone Loss within the Central 1 mm in Patients with Geographic Atrophy

Karl CSAKY (UNITED STATES)

09:40 - 09:48
Progression patterns in foveal-sparing geographic atrophy secondary to amd with double layer sign

Giuseppe QUERQUES (ITALY)

09:48 - 09:56
En Face SS-OCTA Imaging for the Onset and Progression of Macular Atrophy in AMD

Philip ROSENFELD (UNITED STATES)

09:56 - 10:04
Treatment Decisions in Geographic Atrophy: Eyes with GA and NVAMD treated together and Choosing between Pegcetocoplan and Avacicaptad Pegol?

Daniel ROTH (UNITED STATES)

10:04 - 10:12
Green versus Blue autofluorescence of Spectralis in GA

Oudy SEMOUN (FRANCE)

10:12 - 10:20
Evaluating the reliability of a microperimetry-based method for assessing visual function in the junctional zone of geographic atrophy lesion

Nadia WAHEED (UNITED STATES)

29/06
10:30 - 11:00
Break area

Coffee Break

Break

29/06
11:00 - 12:00
Auditorium

IMAGING 1

Session

Moderators: Alexandra MIERE (FRANCE), José PULIDO (UNITED STATES), Richard SPAIDE (UNITED STATES)

11:00 - 11:08
OC-02 - Relationship Between Photopic Focal Microperimetry and Optical Coherence Tomographic Findings in Patients with Geographic Atrophy

Karl CSAKY (UNITED STATES)

11:08 - 11:16
Choridal vascularity index in inherited retinal diseases

Alexandra MIERE (FRANCE)

11:16 - 11:24
New findings in amyloidosis imaging of the eye

José PULIDO (UNITED STATES)

11:24 - 11:32
Distinct pathways to Geographic Atrophy demonstrated by Quantitative Autofluorescence imaging: cellular and clinical implications.

R. Theodore SMITH (UNITED STATES)

11:32 - 11:40
New Imaging Findings in Optic Pit Maculopathy

Richard SPAIDE (UNITED STATES)

11:40 - 11:48
High-Resolution OCT: the retinal vessels

Giovanni STAURENGHI (ITALY)

11:48 - 11:56
Drusen regression without atrophy and the drusen ooze

Jordi MONES (SPAIN)

29/06
12:00 - 12:15
Auditorium

Lecture David SARRAF

Lecture
Type 4 MNV: A New Addition to the OCT AMD Classification

David SARRAF (UNITED STATES)

29/06
12:15 - 13:00
Auditorium

SYMPOSIUM ROCHE - Rethinking nAMD and DME Treatment in the Real-World Era
From Clinical Trials to Real-World Evidence: A Global Perspective

SYMPOSIUM

Moderator: Jean-François KOROBELNIK (FRANCE)

12:15 - 12:25
Asian Perspective: Managing Polypoidal Choroidal Vasculopathy in the Real-World

Salomon Yves COHEN (FRANCE)

12:25 - 12:35
European Perspective: Bridging Clinical Guidelines and Daily Practice for Real-Life Outcomes

Frank HOLZ (GERMANY)

12:35 - 12:45
American Perspective: Translating Real-World Data into Clinical Impact

SriniVas SADDA (UNITED STATES)

12:45 - 13:00
Panel Discussion & Interactive Q&A

Salomon Yves COHEN (FRANCE), Frank HOLZ (GERMANY), Jean-François KOROBELNIK (FRANCE), SriniVas SADDA (UNITED STATES)

29/06
13:00 - 14:00
Break area

Lunch Break

Break

29/06
14:00 - 15:05
Auditorium

Innovation 1

Session

Moderators: Usha CHAKRAVARTHY (UNITED KINGDOM), Michael SINGER (UNITED STATES)

14:00 - 14:08
EYP1901 vs Aflibercept in the  DAVIO 2 multicenter, phase 2 trial: Treatment burden, functional and anatomical outcomes 

Usha CHAKRAVARTHY (UNITED KINGDOM)

14:08 - 14:16
The Susvimo Implant  - indications and implantations tips and tricks

Daniel ROTH (UNITED STATES)

14:16 - 14:24
Subcutaneous Migaldendranib (MGB) for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema:: Interim Results of Chronic Dosing Phase 2 Study

Michael SINGER (UNITED STATES)

14:24 - 14:32
ANX 007 - Targeting Foveal Preservation:  The Next Step in GA Therapy

Karl CSAKY (UNITED STATES)

14:32 - 14:40
Protection of Damage to Cone Synapses by ROCK inhibition: Potential Impact on Subretinal Gene Therapy:

Marco ZARBIN (UNITED STATES)

14:40 - 14:48
Optogenetics in retinal dystrophies and AMD

Jordi MONES (SPAIN)

14:48 - 14:56
Novel findings from innovative high resolution and wide field OCT devices

Bailey FREUND (UNITED STATES)

14:56 - 15:04
Two Years Experience of Intravitreal Injections of Cord Blood Platelet-Rich Plasma in Dry Age-Related Macular Degeneration

Stanislao RIZZO (ITALY)

29/06
15:05 - 15:55
Auditorium

Clinical cases Fellow

Clinical cases

Moderators: Bailey FREUND (UNITED STATES), David SARRAF (UNITED STATES)

15:05 - 15:11
CC-01 - Atypical Peripheral Retinal Vasculopathy

Jun KONG (UNITED STATES)

15:11 - 15:17
Mystery case

Federico BERETTA

15:17 - 15:23
An Atypical Macular Lesion: A Diagnostic Challenge in a Rare Case

Ravid BEN AVI (ISRAEL)

15:23 - 15:29
CC-02 - Occult maculopathy in spinocerebellar ataxia type 7: case report and diagnostic approach

Sorana PACURARIU (FRANCE)

15:29 - 15:35
CC-03 - Mystery case

Inês MENDO (PORTUGAL)

15:35 - 15:41
CC-04 - The great imitator masquerading Behçet disease

Khaled EL MATRI (TUNISIA)

15:41 - 15:47
Mystery case
15:47 - 15:53
Mystery case
29/06
15:55 - 16:25
Auditorium

SYMPOSIUM NOVARTIS - nAMD : When to Switch & When to Stop?

SYMPOSIUM

Moderator: Eric SOUIED (FRANCE)

15:55 - 16:05
Why, when & how to switch aVEGF therapy

Giuseppe QUERQUES (ITALY)

16:05 - 16:15
Development of macular fibrosis and macular atrophy in patients with nAMD

Usha CHAKRAVARTHY (UNITED KINGDOM)

16:15 - 16:25
Round table
29/06
16:25 - 16:40
Break area

Coffee Break

Break

29/06
16:40 - 17:30
Auditorium

Macular Surgery

Session

Moderators: Mohamed BENNANI (MOROCCO), Stanislao RIZZO (ITALY), Marco ZARBIN (UNITED STATES)

16:40 - 16:48
OC-03 - Long term foveation processes after epiretinal membrane surgery

Marco PASTORE (ITALY)

16:48 - 16:56
Methotrexate in the Management of Complex Retina Detachment:

Marco ZARBIN (UNITED STATES)

16:56 - 17:04
Digital Macular Surgery

Stanislao RIZZO (ITALY)

17:04 - 17:12
Optimal Timing for Idiopathic Epiretinal Membrane Peeling Surgery Based on a Preoperative Visual Acuity Threshold.

Laurent KODJIKIAN (FRANCE)

17:12 - 17:20
Water slide ILM embedding technique for a large macular hole

Fukutaro MANO (JAPAN)

17:20 - 17:28
Humain intelligence for surgery in DME

Mohamed BENNANI (MOROCCO)

29/06
16:40 - 17:20
Concordes-invalides

Course

Session Concordes-invalides
Important Points in Organizing, Writing, Revising, and Publishing Scientific Articles

Alexander BRUCKER (UNITED STATES)

29/06
17:20 - 18:00
Concordes-invalides

SIG - Industry, Innovation and Start-up

Session Concordes-invalides
17:20 - 17:25
AVTTX

Susan SCHNEIDER (UNITED STATES)

17:20 - 17:25
Holographic doppler

Michael ATLAN (FRANCE)

17:25 - 17:30
Paree

Rocio BLANCO GARAVITO (FRANCE)

17:25 - 17:30
Artbrains

Claudio XOMPERO (FRANCE)

17:30 - 17:35
Seabelife

Morgane ROUSSELOT (FRANCE)

17:45 - 17:50
Tliak

Romain BUCKO (FRANCE)

17:50 - 17:54
Orisignth pharma

Mariana TRUMAN (ISRAEL)

29/06
17:30 - 19:00
Foyer AB

Poster Session paper and Cocktail

Poster session

30/06
7:00 - 8:00
Concordes-invalides

Women in Retina Networking Breakfast

Session Concordes-invalides
Join us for a dedicated networking breakfast bringing together women in the field of retina from across the globe. This informal yet purposeful gathering provides an opportunity to connect, share experiences, and discuss career development, leadership, and collaboration in ophthalmology. The session aims to foster mentorship, highlight achievements, and promote a supportive and inclusive professional community.
Welcoming participants at all stages of their careers, from early trainees to senior faculty.

30/06
8:00 - 8:54
Auditorium

Free papers session

Free papers session

Moderators: Catherine CREUZOT-GARCHER (FRANCE), Roy SCHWARTZ (UNITED KINGDOM)

08:00 - 08:06
FP-01 - Transretinal puncture with a 41g cannula for posterior residual subretinal fluid
08:06 - 08:12
FP-02 - Epiretinal adjuvants for complex macular holes: lyophilised amniotic membrane or femtosecond laser-cut autologous anterior lens capsule

Thibaud GARCIN (FRANCE)

08:12 - 08:18
FP-03 - Evaluation of ChatGPT-4o in Identifying Exudative Recurrence in Wet Age-Related Macular Degeneration: A Comparative Study with Expert Ophthalmologists

Claudio XOMPERO (FRANCE)

08:18 - 08:24
FP-04 - Prospective realworld comparison of deep learning systems for primary care diabetic retinopathy screening in remote Australia.

Angus TURNER (AUSTRALIA)

08:24 - 08:30
FP-05 - A Novel Calculator to Determine Geographic Atrophy Progression to the Foveal Center with and without Treatment

Ravi PARIKH (UNITED STATES)

08:30 - 08:36
FP-06 - Prevalence and Associations of the Three-Layer Sign in Age-Related Macular Degeneration. The Beijing Eye Study
08:36 - 08:42
FP-07 - Foveal Mid-Phase hyperfluorescent plaque is associated with poorer visual outcomes in central serous chorioretinopathy

Elodie BOUSQUET (FRANCE)

08:42 - 08:48
FP-08 - Non-AMD Reticular Pseudodrusen: How Do They Compare?

Roy SCHWARTZ (UNITED KINGDOM)

08:48 - 08:54
FP-09 - Development of a 360° virtual interface to raise awareness among diabetic patients about the risk of decreased visual acuity

Audrey GIOCANTI (FRANCE)

30/06
8:54 - 9:50
Auditorium

PREVENTION

Session

Moderators: Susan BRESSLER (UNITED STATES), Frank HOLZ (GERMANY)

08:54 - 09:02
Unveiling Statins and Genetics in Age-Related Macular Degeneration

Rufino SILVA (PORTUGAL)

09:02 - 09:10
Lipid metabolisms and AMD – A Viable Therapeutic Target?

Itay CHOWERS (ISRAEL)

09:10 - 09:18
Dietary Supplements for Geographic Atrophy: Evidence For and Against from AREDS:

Susan BRESSLER (UNITED STATES)

09:18 - 09:26
The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis

Johanna SEDDON (UNITED STATES)

09:26 - 09:34
Prevalence Of Visual Impairment in the Elderly population

Sandrine ZWEIFEL (SWITZERLAND)

09:34 - 09:42
MACUSTAR: Clinical endpoints and study designs for intermediate AMD trials

Frank HOLZ (GERMANY)

09:42 - 09:50
Epidemiology and Outcomes of Infectious Endophthalmitis after Intravitreal Injection in Various Retinal Diseases: Data From the Fight Retinal Blindness! Registry

Catherine CREUZOT-GARCHER (FRANCE)

30/06
9:50 - 10:45
Auditorium

IMAGING 2

Session

Moderators: David HUANG (UNITED STATES), SriniVas SADDA (UNITED STATES), Sandrine ZWEIFEL (SWITZERLAND)

09:50 - 09:58
New insight in the formation of soft drusen

Bailey FREUND (UNITED STATES)

09:58 - 10:06
OCT Split-Spectrum Amplitude-Decorrelation Optoretinography in Age-Related Macular Degeneration

David HUANG (UNITED STATES)

10:06 - 10:14
Updated Guidelines for Imaging the Choriocapillaris in Eyes with Age-Related Macular Degeneration using Swept-Source OCT Angiography

Philip ROSENFELD (UNITED STATES)

10:14 - 10:22
Characterization of Bruch’s membrane defects in neovascular AMD using hi-res OCT

SriniVas SADDA (UNITED STATES)

10:22 - 10:30
SNIFR AND CARPET and the Importance of Mid Peripheral VR Traction

David SARRAF (UNITED STATES)

10:30 - 10:38
Update on Dome Shaped  Macula

Alain GAUDRIC (FRANCE)

10:38 - 10:46
Wide Field OCTA imaging in retinitis pigmentosa

Eric SOUIED (FRANCE)

30/06
10:45 - 11:15
Break area

Coffee Break

Break

30/06
11:15 - 12:15
Auditorium

Neovascular AMD

Session

Moderators: Caroline BAUMAL (UNITED STATES), Anat LOEWENSTEIN (ISRAEL), Eric SOUIED (FRANCE)

11:15 - 11:23
New Anti-VEGF Agents for Neovascular AMD: Durable or More Durable

Susan BRESSLER (UNITED STATES)

11:23 - 11:31
Findings from the 4 T BIG study

Usha CHAKRAVARTHY (UNITED KINGDOM)

11:31 - 11:39
Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration

Jean-François KOROBELNIK (FRANCE)

11:39 - 11:47
OC-04 - PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults with Neovascular Age-related Macular Degeneration: 52-week Results

Anat LOEWENSTEIN (ISRAEL)

11:47 - 11:55
Choroidal Thickness Changes After Intravitreal Faricimab, Brolucizumab, and High dose Aflibercept  injections in Treatment-Naïve Neovascular AMD

Sam RAZAVI (FRANCE)

11:55 - 12:03
Quantifying Effects of Lifestyle Changes on Progression to Advanced Age-Related Macular Degeneration in High Genetic Risk Individuals

Johanna SEDDON (UNITED STATES)

12:03 - 12:11
OC-05 - Recommendations for OCT Angiography Reporting in Age-Related Macular degeneration: A Delphi Approach by International Experts

Roy SCHWARTZ (UNITED KINGDOM)

30/06
12:15 - 12:30
Auditorium

Lecture Larry YANNUZZI

Lecture
The Gabriel Coscas Lecture

Larry YANNUZZI (UNITED STATES)

30/06
12:30 - 13:15
Auditorium

SYMPOSIUM BAYER - Innovations and Perspectives in Anti-VEGF Therapies: Towards Optimized Practice in Ophthalmology

SYMPOSIUM

Moderator: Eric SOUIED (FRANCE)

12:30 - 12:41
Beyond Clinical Trials: Real-World Promises of the Therapeutic Arsenal

Laurent KODJIKIAN (FRANCE)

12:41 - 12:52
Durability: From Clinical Data to Real Life

Sandrine ZWEIFEL (SWITZERLAND)

12:52 - 13:03
Combining Treatment and AI for a Personalized Care Approach

Anat LOEWENSTEIN (ISRAEL)

13:03 - 13:15
Discussion

Laurent KODJIKIAN (FRANCE), Anat LOEWENSTEIN (ISRAEL), Sandrine ZWEIFEL (SWITZERLAND)

30/06
13:15 - 13:20
Auditorium

Image contest winner/ Poster winner 15'

Session

30/06
13:20 - 14:20
Break area

Lunch Break

Break

30/06
14:20 - 15:10
Auditorium

Clinical cases

Clinical cases

Moderators: Richard SPAIDE (UNITED STATES), Larry YANNUZZI (UNITED STATES)

14:20 - 14:26
1 -Mystery case
14:26 - 14:32
2 -Mystery case
14:32 - 14:38
1- Mystery Retina Case

William F. MIELER (UNITED STATES)

14:38 - 14:44
3- Mystery Case
14:44 - 14:50
2 - Mystery Retina Case

Richard SPAIDE (UNITED STATES)

14:50 - 14:56
4 - Mystery Case

Philip ROSENFELD (UNITED STATES)

14:56 - 15:02
5 - Mystery Case
15:02 - 15:08
6 - Mystery Case
30/06
15:10 - 16:05
Auditorium

IMAGING 3

Session

Moderators: Karl CSAKY (UNITED STATES), R. Theodore SMITH (UNITED STATES)

15:10 - 15:18
OC-14 - Contribution of OCT A in the long-term management of neovascular AMD in TAE.

Hassiba OUBRAHAM (FRANCE)

15:18 - 15:26
Structure - Function Correlates with Hi-Res Optical Coherence Tomography Imaging

Karl CSAKY (UNITED STATES)

15:26 - 15:34
The Ellipsoid zone and its association with Subretinal Drusenoid Deposits: a story of hypoxia with clinical implications.

R. Theodore SMITH (UNITED STATES)

15:34 - 15:42
Hidden in Plain Site - Microscopic Secrets of Clinical OCT Images Revealed Using Multi-Perspective Non-Confocal Adaptive Optics SLO

Richard ROSEN (UNITED STATES)

15:42 - 15:50
OC-06 - Reduced Fundus Autofluorescence in Highly Myopic Eyes with Tessellated Fundus and Diffuse Chorioretinal Atrophy

Aude COUTURIER (FRANCE)

15:50 - 15:58
Update on Systemic Medications and Retinal Toxicity including new guidelines for monitoring Hydroxychloroquine

William F. MIELER (UNITED STATES)

15:58 - 16:06
OC-07 - Acute Annular Outer Retinopathy: Clinical and Multimodal Imaging Features
30/06
16:05 - 16:45
Auditorium

SYMPOSIUM ABBVIE - Innovations in the Management of Macular Edema: Today and Tomorrow

SYMPOSIUM
16:05 - 16:25
What is the Contribution of New Imaging Technologies to Current Clinical Practice?

Marco ZARBIN (UNITED STATES)

16:25 - 16:45
The therapeutic options for the future.

Eric SOUIED (FRANCE)

30/06
16:45 - 17:10
Break area

Coffee Break

Break

30/06
17:10 - 18:00
Auditorium

Retina Vascular Disorders

Session

Moderators: William F. MIELER (UNITED STATES)

17:10 - 17:18
Comparison of Adult and Pediatric Eyes with Coats’ Disease using Multimodal Imaging

Caroline BAUMAL (UNITED STATES)

17:18 - 17:26
Macular teleangiectasia type 2: EZ-loss progression treatment approaches

Frank HOLZ (GERMANY)

17:26 - 17:34
The Hermes Study

Alexandra MIERE (FRANCE)

17:34 - 17:42
OC-08 - Targeted photocoagulation of capillary macroaneurysms using navigated focal laser technology
17:42 - 17:50
Ocular Manifestations of Cerebral Aneurysmal Stenting

Alexander BRUCKER (UNITED STATES)

17:50 - 17:58
OC-09 - Prevalence and Associations of Central Serous Chorioretinopathy. The Beijing Eye Study.
01/07
8:00 - 8:57
Auditorium

Free papers session

Free papers session

Moderators: Salomon Yves COHEN (FRANCE), Amani FAWZI (UNITED STATES)

08:00 - 08:06
FP-10 - Prevalence of Visual Acuity Loss and Its Correlates in Highly Myopic Eyes: Insights from the French Myopia Institute Cohort

Nicolas AREJ (FRANCE)

08:06 - 08:12
FP-11 - Photobiomodulation (PBM) in Dry Age-related Macular Degeneration: one-year outcomes in a clinical setting
08:12 - 08:18
FP-12 - Quantitative analysis of macular microvasculature following Photobiomodulation for intermediate stage of age-related macular degeneration: A Swept-source optical coherence tomography angiography study

Manal BENLAHBIB (FRANCE)

08:18 - 08:24
FP-13 - Vascular flow remodeling of macular neovascularization in age-related macular degeneration treated with Aflibercept: four years of follow-up

Rita SERRA (ITALY)

08:24 - 08:30
FP-14 - Baseline and Early Treatment Response Variables Associated With Faricimab Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses

Eric SOUIED (FRANCE)

08:30 - 08:36
URPED : an update

Salomon Yves COHEN (FRANCE)

08:36 - 08:42
FP-17 - Quantitative Analysis of Choriocapillaris Using Swept-Source Optical Coherence Tomography Angiography in Patients With Sarcoïdosis

Hoang Mai LE (FRANCE)

08:42 - 08:48
FP-15 - Retinal Sarcoidosis: A Case Series with New Insights from Multi-Modal Imaging

Adrian FUNG (AUSTRALIA)

08:48 - 08:54
FP-16 - Comparative diagnostic performance of various ancillary tests for the detection of optic disc swelling

Sarah TOUHAMI (FRANCE)

01/07
8:57 - 9:46
Auditorium

Artificial Intelligence - Oculomics

Session

Moderators: Pearce KEANE (UNITED KINGDOM), Alexandra MIERE (FRANCE), Nadia WAHEED (UNITED STATES)

08:58 - 09:06
Navigating the Explosion of AI in the Peer-reviewed Medical Literature: Session

Neil BRESSLER (UNITED STATES)

09:06 - 09:14
Leveraging synthetic data for creation of ophthalmic AI

Pearce KEANE (UNITED KINGDOM)

09:14 - 09:22
Pivotal Study towards Effectiveness of Artificial Intelligence (AI) based analysis of Home OCT and its Clinical Implications

Anat LOEWENSTEIN (ISRAEL)

09:22 - 09:30
Association between abnormal retinal perfusion indices by optical coherence tomography angiography and myocardial flow reserve by positron emission tomography/computed tomography.

Nadia WAHEED (UNITED STATES)

09:30 - 09:38
Doppler OCT of Retinal Artery Hemodynamics

David HUANG (UNITED STATES)

09:38 - 09:46
Quantifying capillary pericytes : clinical impact in diabetic retinopathy and future direction

Amani FAWZI (UNITED STATES)

01/07
9:46 - 10:06
Auditorium

SYMPOSIUM CELLTRION HEALTHCARE - Biosimilars in retinal diseases : update in 2025

SYMPOSIUM
09:46 - 09:56
Biosimilars : what should we know ?

Laurent KODJIKIAN (FRANCE)

09:56 - 10:06
Biosimilars : what is new in 2025 ?

Sebastian WOLF (SWITZERLAND)

01/07
10:10 - 10:25
Auditorium

Lecture Richard SPAIDE

Lecture
FOVEATION

Richard SPAIDE (UNITED STATES)

01/07
10:25 - 10:55
Break area

Coffee Break

Break

01/07
10:55 - 11:51
Auditorium

Diabetes

Session

Moderators: Itay CHOWERS (ISRAEL), Michael ELMAN (UNITED STATES), Laurent KODJIKIAN (FRANCE)

10:55 - 11:03
Diabetic Retinopathy Lesion Types and Distribution on Ultrawide Field Imaging and the Risk of Diabetic Retinopathy Worsening Over Time (Protocol AA)

Michael ELMAN (UNITED STATES)

11:03 - 11:11
Exploring AI-Based OCT Parameters to Evaluate Diabetic Macular Edema Treatment Outcome

Itay CHOWERS (ISRAEL)

11:11 - 11:19
Differential resolution of diabetic hard exudates with anti-VEGF therapy

SriniVas SADDA (UNITED STATES)

11:19 - 11:27
Eryldex for DmE 

Michael SINGER (UNITED STATES)

11:27 - 11:35
Ultrawide-Field OCT: Definition and Clinical Applications

David HUANG (UNITED STATES)

11:35 - 11:43
OC-10 - Restoret for the Treatment of Diabetic Macular Edema: Results from the AMARONE Phase 1b/2a Clinical Trial

Charles MILLER (UNITED STATES)

11:43 - 11:51
Volumetric (3D) Capillary Nonperfusion on Optical Coherence Tomography Angiography Pinpoint The Axial Location of Early Ischemia in Diabetes Without Retinopathy

Amani FAWZI (UNITED STATES)

01/07
11:52 - 12:40
Auditorium

Innovation 2

Session

Moderators: Jose SAHEL (UNITED STATES)

11:52 - 12:00
Retinal prosthesis in AMD

Jose SAHEL (UNITED STATES)

12:00 - 12:08
PRIORIT2 Functional outcomes of the PRIMA microstimulation system in patients with geographic atrophy due to AMD

Frank HOLZ (GERMANY)

12:08 - 12:16
OC-11 - Oral Gildeuretinol in Geographic Atrophy secondary to AMD: Safety and Efficacy from SAGA, a 2-year, Randomized, Double-masked, Placebo-controlled Study

Ivan SUÑER (UNITED STATES)

12:16 - 12:24
AI for clinical trial recruitment in AMD 
12:24 - 12:32
OC-12 - MonOEil, a ChatGPT-based education tool in ophthalmology

Carl Joe MEHANNA (FRANCE)

12:32 - 12:40
Lucia is here to Help

Eric SOUIED (FRANCE)

01/07
12:40 - 13:20
Auditorium

Innovation 3

Session

Moderators: William F. MIELER (UNITED STATES), Eric SOUIED (FRANCE)

12:40 - 12:48
The importance of Melanin

Giovanni STAURENGHI (ITALY)

12:48 - 12:56
AAV based gene therapy for the treatment of XLRP

Nadia WAHEED (UNITED STATES)

12:56 - 13:04
Verona Study

Michael SINGER (UNITED STATES)

13:04 - 13:12
Update on Drug delivery to the Posterior Segment

William F. MIELER (UNITED STATES)

13:12 - 13:20
Better Retina Clinical Trials through Liquid Biopsy Innovation
13:20 - 13:28
Near-Real Surgical Specimens (NRSS): A Novel Platform for Standardized Assessment

David ALMEIDA (UNITED STATES)

01/07
13:20 - 14:00
Break area

Lunch Break

Break

01/07
14:30 - 15:30
Auditorium

SIG - AI IN OPHTHALMOLOGY: FROM IDEA TO ALGORITHM, FROM CODE TO CLINIC

Session

Moderators: Alexandra MIERE (FRANCE)

14:30 - 14:40
Building AI in Ophthalmology: The Hidden Importance of Data Infrastructure

Pearce KEANE (UNITED KINGDOM)

14:40 - 14:50
Training Ophthalmic AI Models: Code-Free to Custom Pipeline

Alexandra MIERE (FRANCE)

14:50 - 15:00
OC-13 - Validating AI for Ophthalmology: AI as a Medical Device

Ariel ONG (UNITED KINGDOM)

15:00 - 15:10
Applications of large language models in diabetic retinopathy screening

Claudio XOMPERO (FRANCE)

15:10 - 15:20
Evired: Developing AI for Modern Diabetic Retinopathy Diagnosis and Prognosis

Aude COUTURIER (FRANCE)

15:20 - 15:30
Panel Discussion and Audience Q&A
01/07
15:30 - 16:30
Auditorium

SIG - SENSGENE - Rare Eye Diseases

Session
15:30 - 15:42
Stargardt Disease

Isabelle AUDO

15:42 - 15:54
North Carolina Macular Dystrophies Cohort

Isabelle MEUNIER

15:54 - 16:06
Best Disease

Bart LEROY (BELGIUM)

16:06 - 16:18
Foveal Hypoplasia

Giacomo BACCI (ITALY)

16:18 - 16:30
Longitudinal characterisation of chorioretinal atrophy after subretinal gene therapy with Voretigene Neparvovec in RPE65-associated retinal dystrophy

Philipp HERMANN (GERMANY)